Stock 603990 SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Suzhou MedicalSystem Technology Co., Ltd.

Equities

603990

CNE100002ZY8

Advanced Medical Equipment & Technology

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 29/04/2024 BST 		5-day change 1st Jan Change
10.24 CNY -0.78% Intraday chart for Suzhou MedicalSystem Technology Co., Ltd. +2.71% -20.74%
04-29 Suzhou MedicalSystem Technology Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-03 Tranche Update on Suzhou MedicalSystem Technology Co., Ltd.'s Equity Buyback Plan announced on February 7, 2024. CI

Valuation

Fiscal Period: December 2019 2020 2022 2023 2024 2025
Capitalization 1 3,857 4,678 4,044 3,918 3,105 -
Enterprise Value (EV) 1 3,857 4,678 4,044 3,918 3,105 3,105
P/E ratio 82.6 x 134 x 119 x -14.7 x 15.5 x 5.95 x
Yield 0.37% 0.21% - - - -
Capitalization / Revenue 11.6 x 15.2 x - 6.34 x 0.79 x 0.46 x
EV / Revenue 11.6 x 15.2 x - 6.34 x 0.79 x 0.46 x
EV / EBITDA - - - - - -
EV / FCF - - - - - -
FCF Yield - - - - - -
Price to Book 7.82 x 4.33 x - 3.61 x 2.29 x 1.7 x
Nbr of stocks (in thousands) 244,205 246,064 275,684 303,244 303,244 -
Reference price 2 15.79 19.01 14.67 12.92 10.24 10.24
Announcement Date 24/04/20 16/04/21 28/04/23 30/04/24 - -
1CNY in Million2CNY
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2022 2023 2024 2025
Net sales 1 333.1 308.1 - 618.1 3,906 6,724
EBITDA - - - - - -
EBIT 1 53.93 48.72 - -261.9 254 660
Operating Margin 16.19% 15.81% - -42.38% 6.5% 9.82%
Earnings before Tax (EBT) 1 53.92 48.57 - -262 253 659
Net income 1 46.89 35.44 33.56 -269.4 201 527
Net margin 14.08% 11.5% - -43.59% 5.15% 7.84%
EPS 2 0.1912 0.1420 0.1231 -0.8800 0.6600 1.720
Free Cash Flow - - - - - -
FCF margin - - - - - -
FCF Conversion (EBITDA) - - - - - -
FCF Conversion (Net income) - - - - - -
Dividend per Share 0.0578 0.0390 - - - -
Announcement Date 24/04/20 16/04/21 28/04/23 30/04/24 - -
1CNY in Million2CNY
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2022 2023 2024 2025
Net Debt - - - - - -
Net Cash position - - - - - -
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow - - - - - -
ROE (net income / shareholders' equity) 9.68% 5.66% - -22.3% 14.6% 27.9%
ROA (Net income/ Total Assets) 6.35% 3.11% - - - -
Assets 1 738.7 1,141 - - - -
Book Value Per Share 2 2.020 4.390 - 3.580 4.470 6.040
Cash Flow per Share 2 0.0900 0.3600 - -1.030 -1.520 -0.0800
Capex 1 12.4 8.86 - 600 1,202 1,201
Capex / Sales 3.73% 2.88% - 97.04% 30.77% 17.86%
Announcement Date 24/04/20 16/04/21 28/04/23 30/04/24 - -
1CNY in Million2CNY
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
10.24
Average target price
-
Consensus

EPS Revisions

Estimates Revisions

Annual profits - Rate of surprise

Company calendar

Sector Medical Software & Technology Services

1st Jan change Capi.
SUZHOU MEDICALSYSTEM TECHNOLOGY CO., LTD. Stock Suzhou MedicalSystem Technology Co., Ltd.
-20.74% 429M
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+18.46% 7.84B
SECTRA AB Stock Sectra AB
+22.71% 3.95B
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-17.95% 3.11B
OMNICELL, INC. Stock Omnicell, Inc.
-19.93% 1.38B
LUNIT INC. Stock Lunit Inc.
-30.65% 1.21B
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+4.36% 933M
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-34.81% 911M
VERADIGM INC. Stock Veradigm Inc.
-26.60% 829M
SURGICAL SCIENCE SWEDEN AB Stock Surgical Science Sweden AB
-15.56% 728M
Medical Software & Technology Services
  1. Stock Market
  2. Equities
  3. 603990 Stock
  4. Financials Suzhou MedicalSystem Technology Co., Ltd.